Columbia University College of Physicians and Surgeons, USA

Email: [email protected]

1984  Luis Vives High School, Palma de Mallorca, Baleares, Spain.

1. Campbell, A., Adamo, A., Bektik, E., et al. (2026). Inhibition of the serotonin transporter and risk of heart valve disease: A systematic review and meta-analysis. European Journal of Pharmacology, 1027, Article 178954.
2. Arai, H., & Grau, J. B. (2026). Beyond Annuloplasty: Anatomy-based Tricuspid Valve Repair for Right Ventricular Dysfunction. European Journal of Cardio-Thoracic Surgery, 68(5), Article ezag160.
3. Camillo, C., Moroi, M. K., Kosuri, Y., et al. (2026). Ex Vivo Hypothermic Perfusion Enables 48-Hour Heart Preservation and Bench-Top Functional Recovery via Normothermic Reperfusion in a Porcine Model. Journal of the American Heart Association, 15(7), Article e045800.
4. Jabagi, H., Shaw, R. E., Kontorovich, A. R., et al. (2026). Utilization of current ACC/AHA genetic testing recommendations for thoracic aortic disease at a large adult aortic center. Genetics in Medicine, 28(4), Article 102069.
5. Levine, D., Camillo, C., Castillero, E., et al. (2026). Serotonin transporter downregulation is associated with aortic stenosis, and early profibrotic remodeling is mitigated by pharmacological inhibition of HTR2B receptor. Frontiers in Cardiovascular Medicine, 13, Article 1729078.
6. Rahim, M., Habibi, M., Rahim, H., et al. (2025). Dynamic Left Ventricular Outflow Tract Obstruction in a Patient Post Transcatheter Aortic Valve Replacement Induced by Left Bundle Branch Area Pacing Following Atrioventricular Junction Ablation. Circulation, 152(Suppl 3), Article 4362838.
7. Guo, M. H., Appoo, J. J., Demers, P., et al. (2025). Surgery Versus Surveillance: A Quality-of-Life Analysis of Patients With Moderately Dilated Aortic Root or Ascending Aorta. European Journal of Cardio-Thoracic Surgery, 67(9), Article ezaf288.
8. Makarem, A., Appoo, J. J., Boodhwani, M., et al. (2025). Patient Selection for Surgery vs Surveillance in Moderately Dilated Ascending Aorta: Insights From Treatment in Thoracic Aortic Aneurysm: Surgery versus Surveillance (TITAN:SvS), an International Prospective Trial. Annals of Thoracic Surgery, 120(1), 25–32.
9. Fang, J., Chen, Y., Liu, Y. N., et al. (2025). Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: Lessons Learned After the Learning Curve Period. Circulation-Cardiovascular Interventions, 18(5), Article e015044.
10. Dagher, O., Appoo, J. J., Herget, E., et al. (2025). Impact of nondiameter aortic indices on surgical eligibility: Results from the Treatment in Thoracic Aortic Aneurysm: Surgery Versus Surveillance (TITAN: SvS) randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery, 169(3).
11. Alemany, V. S., Fortier, J., Gupta, H., et al. (2024). A rare case of IgG4-related aortitis in the thoracic aorta mimicking an intramural hematoma: navigating the diagnostic labyrinth. Journal of Cardiothoracic Surgery, 19(1), Article 599.
12. Castillero, E., Camillo, C., Levine, D., et al. (2025). Serotonin transporter deficiency in mice results in an increased susceptibility to HTR2B-dependent pro-fibrotic mechanisms in the cardiac valves and left ventricular myocardium. Cardiovascular Pathology, 74, Article 107689.
13. Fortier, J. H., Thapa, Y., Crean, A. M., et al. (2024). Invasive Management of Hypertrophic Cardiomyopathy With Clinically Important Obstruction: Surgical Myectomy Is Superior, but Only When Accessible. Canadian Journal of Cardiology, 40(5), 843–850.
14. Jabagi, H., Shaw, R. E., Gharibeh, L., et al. (2024). Patient Characteristics and Outcomes Associated with Sentinel Protection Device Use in Patients with Aortic Valve Disease Undergoing TAVR in a "Real-World" Setting. Reviews in Cardiovascular Medicine, 25(1), Article 3.
15. Kotoku, N., Serruys, P. W., Kageyama, S., et al. (2023). CCTA-based CABG SYNTAX Score: a tool to evaluate completeness of coronary segment revascularization after bypass surgery. International Journal of Cardiovascular Imaging, 39(12), 2531–2543.
16. Shahinian, J. H., Lappiere, H., Grau, J., & Glineur, D. (2024). Total Arterial Revascularization: Evaluating the Length of the Radial Artery in a Composite Graft Configuration. Annals of Thoracic and Cardiovascular Surgery, 30(1), Article oa.23-00084.
17. Gupta, H., Spanopoulous, B., Lubat, E., et al. (2023). Real-world approach to comprehensive artificial intelligence-aided CT evaluation of coronary artery disease in 530 patients: A retrospective study. Heliyon, 9(9), Article e19974.
18. Jabagi, H., Levine, D., Gharibeh, L., et al. (2023). Implications of Bicuspid Aortic Valve Disease and Aortic Stenosis/Insufficiency as Risk Factors for Thoracic Aortic Aneurysm. Reviews in Cardiovascular Medicine, 24(6).
19. Grau, J. B., & Fortier, J. H. (2023). Patients with hypertrophic cardiomyopathy deserve heart teams, and those heart teams need surgeons. European Journal of Cardio-Thoracic Surgery, 63(3), Article ezad096.
20. Castillero, E., Fitzpatrick, E., Keeney, S. J., et al. (2023). Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation. Science Translational Medicine, 15(677), Article eadc9606.
21. Grau, J. B. (2022). Statins for secondary prevention after coronary artery bypass grafting: Pleiotropic effects and dementia risk Commentary. Journal of Thoracic and Cardiovascular Surgery, 164(6), 1887–1888.
22. Grau, J. B. (2022). Prosthesis-Patient Mismatch: Troubles to Come for TAVR Patients. Annals of Thoracic Surgery, 114(5), 1620–1620.

Profile Details